Effects of Neo40(TM) With Caffeine on Cycling Time Trial Performance

NCT ID: NCT01710761

Last Updated: 2013-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute supplementation of Neo40(TM), a nitrate lozenge, will improve cycling performance

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nitrate supplement with caffeine

Group Type ACTIVE_COMPARATOR

Nitrate supplement with caffeine

Intervention Type DIETARY_SUPPLEMENT

Lozenge consisting of beetroot and 75 mg caffeine

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Same form factor and flavor as test lozenge but contains no active ingredients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo

Same form factor and flavor as test lozenge but contains no active ingredients

Intervention Type DIETARY_SUPPLEMENT

Nitrate supplement with caffeine

Lozenge consisting of beetroot and 75 mg caffeine

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Regular commuter cyclist or spin class participant
* Male (VO2max \< 50) or Female (VO2max \< 45)
* Healthy
* Blood pressure below 140/90
* Non-smoker

Exclusion Criteria

* Does not cycle 2-3 times/week
* Regular consumption of performance-enhancing substances
* Type I or Type II diabetes
* Renal, hepatic or cardiac disease
* Current infectious disease
Minimum Eligible Age

21 Years

Maximum Eligible Age

49 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Neogenis Laboratories

OTHER

Sponsor Role collaborator

University of Texas at Austin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lynne Kammer-Kerwick, MSE, MA

Role: PRINCIPAL_INVESTIGATOR

The University of Texas at Austin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Texas at Austin

Austin, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012-05-0033

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Caffeine Kinetics and CrossFit®-Specific Performance
NCT05516212 RECRUITING PHASE2/PHASE3
COMP-4 Supplementation and Brachial Artery FMD
NCT05595915 ACTIVE_NOT_RECRUITING PHASE1/PHASE2